Addison's sykdom (binyrebarksvikt)

Autoimmune polyendokrine syndromer

Hypoparathyroidisme

Hormonsykdommer

Vitenskapelig artikkel

• Mikael Thomassen Neset; Roy Miodini Nilsen; Kristian Løvås et al. (2025). Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease. (ekstern lenke)
• Mikael Thomassen Neset; Arve Ulvik; Kristian Løvås et al. (2025). Insight into the metabolic shifts in Graves’ hyperthyroidism: a study of acylcarnitine and lipid profiles. (ekstern lenke)
• Dmytro Fishman; Kai Kisand; Christina Hertel et al. (2017). Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins. (ekstern lenke)
• Iren Drange Hjellestad; Eirik Søfteland; Roy Miodini Nilsen et al. (2016). Abdominal aortic aneurysms - glycaemic status and mortality. (ekstern lenke)
• Paal Methlie; Eystein Sverre Husebye; Simon Steinar Hustad et al. (2011). Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease. (ekstern lenke)
• Agnethe Berglund; Line Cleemann; Bergithe Eikeland Oftedal et al. (2018). 21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Kine Susann Waade Edvardsen; Alexander Hellesen; Eystein Sverre Husebye et al. (2016). Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. (ekstern lenke)
• Ingrid Nermoen; Ivar Følling; Kjetil Vegge et al. (2009). Two adults with adrenal myelolipoma and 21-hydroxylase deficiency. (ekstern lenke)
• Anna Chuprin; Ayelet Avin; Yael Goldfarb et al. (2015). The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. (ekstern lenke)
• Marianne Astor; Wendy Zhu; Sigrídur Björnsdóttir et al. (2018). Is there a need for an emergency card in hypoparathyroidism?. (ekstern lenke)
• Anette Susanne Bøe; Per Morten Knappskog; Anne Grete Myhre et al. (2002). Mutational analysis of the autoimmune regulator gene in sporadic autoimmune Addison`s disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Eystein Sverre Husebye (2009). Skin changes as diagnostic aid. (ekstern lenke)
• Takaki Asano; Bertrand Boisson; Fanny Onodi et al. (2021). X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. (ekstern lenke)
• Iren Drange Hjellestad; Eirik Wigtil Søfteland; Eystein Sverre Husebye et al. (2019). HbA1c predicts long-term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study.. (ekstern lenke)
• Katerina Simunkova; Kristian Løvås; Paal Methlie et al. (2022). Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency. (ekstern lenke)
• Kai Kisand; Maire Link; Anette Susanne Bøe Wolff et al. (2008). Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. (ekstern lenke)
• Paul Bastard; Sara E. Vazquez; Jamin Liu et al. (2023). Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. (ekstern lenke)
• F Skjöldberg; L Grimelius; F Rorsman et al. (1998). A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the Von Hippel Lindau disease or ret genes. (ekstern lenke)
• Sigrid Aslaksen; Anette Susanne Bøe Wolff; Magnus Dehli Vigeland et al. (2019). Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. (ekstern lenke)
• Ingeborg Brønstad; Beate Skinningsrud; Eirik Bratland et al. (2014). CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. (ekstern lenke)
• Grethe Åstrøm Ueland; Paal Methlie; Dag Eirik Jøssang et al. (2018). Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion. (ekstern lenke)
• Saila Laakso; Elina Hopolainen; Corrado Betterle et al. (2021). Pregnancy Outcome in Women With APECED (APS-1): A Multicenter Study on 43 Females With 83 Pregnancies. (ekstern lenke)
• Elinor Margrethe Vogt; Eirik Bratland; Siren Berland et al. (2024). Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. (ekstern lenke)
• Grethe Åstrøm Ueland; Hans Olav Ueland; Ann-Elin Meling Stokland et al. (2023). Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease. (ekstern lenke)
• Anette Susanne Bøe Wolff; Anna L. Mitchell; Heather J. Cordell et al. (2015). CTLA-4 as a genetic determinant in autoimmune Addison's disease. (ekstern lenke)
• Åse Bjorvatn Sævik; Anna Karin Åkerman; Kaja Grønning et al. (2017). Clues for early detection of autoimmune Addison's disease - myths and realities. (ekstern lenke)
• Maribel Aranda-Guillén; Ellen Christine Røyrvik; Sara Fletcher-Sandersjöö et al. (2023). A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies. (ekstern lenke)
• Andrea D. Short; Alisdair Boag; Brian Catchpole et al. (2013). A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds. (ekstern lenke)
• Caleigh Mandel-Brehm; Sara E. Vazquez; Christopher Liverman et al. (2023). Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy. (ekstern lenke)
• Daniel Eriksson; Ellen Christine Røyrvik; Maribel Aranda-Guillen et al. (2021). GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. (ekstern lenke)
• K Løvås; Martina M. Erichsen; ES Husebye et al. (2005). Primær binyrebarksvikt - årsaker, diagnostikk og behandling. (ekstern lenke)
• Ng’weina Francis Magitta; AS Bøe; S Johansson et al. (2008). A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (ekstern lenke)
• Ann-Elin Meling Stokland; Marie Austdal; Bjørn Gunnar Nedrebø et al. (2023). Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy. (ekstern lenke)
• M Stridsberg; Eystein S.Junior Husebye (1997). Chromogranin A and chromogranin B in phaeochromocytoma. (ekstern lenke)
• Ann-Elin Meling Stokland; Grethe Åstrøm Ueland; Kari Lima et al. (2022). Autoimmune Thyroid Disorders in Autoimmune Addison Disease. (ekstern lenke)
• Leila S. Sozaeva; Lubov I Zilberman; Galina N Svetlova et al. (2018). Clinical and immunological characteristics of diabetes mellitus in patients with autoimmune polyglandular syndrome type 1 in Russia. (ekstern lenke)
• Nils Landegren; Donald Sharon; Eva Freyhult et al. (2016). Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Anette Susanne Bøe Wolff; Adrien Katalin Sarkadi; László Maródi et al. (2013). Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. (ekstern lenke)
• Adrianna Jebrzycka; Lars Breivik; David William Peter Dolan et al. (2025). Aire-dependent interferon signalling shapes thymocyte maturation and central tolerance in mice. (ekstern lenke)
• Thea Sjøgren; Jan-Inge Bjune; Eystein Sverre Husebye et al. (2024). Regulatory T cells in autoimmune primary adrenal insufficiency. (ekstern lenke)
• Anne Grethe Myhre; H. Aarsetøy; D.E. Undlien et al. (2003). High frequency of coeliac disease among patients with autoimmune adrenocortical failure. (ekstern lenke)
• Grethe Åstrøm Ueland; Thea Grinde; Paal Methlie et al. (2020). Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas. (ekstern lenke)
• Andrea D. Short; Brian Catchpole; Alisdair Boag et al. (2014). Putative candidate genes for canine hypoadrenocorticism (Addison's disease) in multiple dog breeds. (ekstern lenke)
• Felix Beuschlein; Tobias Else; Irina Bancos et al. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. (ekstern lenke)
• A-G Myhre; P Bjørses; A Dalen et al. (1998). Three sisters with Addison's disease. (ekstern lenke)
• Sara Öster; Daniela Esposito; Maribel Aranda-Guillén et al. (2023). Self-management and hospitalization in 615 Swedish patients with Addison's disease during the coronavirus disease 2019 pandemic: a retrospective study. (ekstern lenke)
• Marissa Penna-Martinez; Gesine Meyer; Anette Susanne Bøe Wolff et al. (2021). Vitamin D status and pathway genes in five European autoimmune Addison's disease cohorts. (ekstern lenke)
• Iivo Hetemäki; Hanna Jarva; Nicolas Kluger et al. (2016). Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. (ekstern lenke)
• Eystein S.Junior Husebye; Eirik Bratland; Geir Bredholt et al. (2006). The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. (ekstern lenke)
• Ingeborg Brønstad; Lars Ertesvåg Breivik; Paal Methlie et al. (2014). Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. (ekstern lenke)
• Beate Skinningsrud; Eystein Sverre Husebye; Simon H. Pearce et al. (2008). Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. (ekstern lenke)
• Marianne Astor; Kristian Løvås; Anette Susanne Bøe Wolff et al. (2015). Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. (ekstern lenke)
• H.H. Hedstrand; J Perheentupa; O Ekwall et al. (1999). Antibodies Against Hair Follicles are Associated with Alopecia Totalis in Autoimmune Polyendocrine Syndrome Type I. (ekstern lenke)
• Anne Grethe Myhre; M. Halonen; P. Eskelin et al. (2001). Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. (ekstern lenke)
• Sophie Bensing; Sergueï O. Fetissov; Jan Mulder et al. (2007). Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Eva Martina Moter Erichsen; Eystein Sverre Husebye; Trond Melbye Michelsen et al. (2010). Sexuality and Fertility in Women with Addison's Disease. (ekstern lenke)
• Annika Søderbergh; A.G. Myhre; Olov Ekwall et al. (2004). Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Jonathan Massey; Alisdair Boag; Andrea D. Short et al. (2013). MHC class II association study in eight breeds of dog with hypoadrenocorticism. (ekstern lenke)
• Bergithe Eikeland Oftedal; Amund Holte Berger; Øyvind Bruserud et al. (2023). A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2011). Cellular immunity and immunopathology in autoimmune Addison’s disease. (ekstern lenke)
• Anne Grethe Myhre; A. Stray-Pedersen; S. Spangen et al. (2004). Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. (ekstern lenke)
• A. Storstein; Sissel Evy Monstad; Hanne Linda Nakkestad et al. (2004). Paraneoplastic antibodies against HuD detected by a sensitive radiobinding assay. (ekstern lenke)
• Agnieszka Pazderska; Bergithe Eikeland Oftedal; Catherine M. Napier et al. (2016). A variant in the BACH2 gene is associated with susceptibility to autoimmune addison's disease in humans. (ekstern lenke)
• Håkan Hedstrand; Olov Ekwall; Jan Haavik et al. (2000). Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Mohammad Alimohammadi; Noémie Dubois; Filip Sköldberg et al. (2009). Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen. (ekstern lenke)
• Haydee Artaza; Daniel Eriksson; Ksenia Lavrichenko et al. (2024). Rare copy number variation in autoimmune Addison’s disease. (ekstern lenke)
• O Ekwall; HH Hedstrand; Jan Haavik et al. (2000). Pteridin dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Eystein Husebye; Anette Susanne Bøe; Fredrik Rorsman et al. (2000). Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. (ekstern lenke)
• [Mangler fornavn] Gebre-Medhin; Eystein S.Junior Husebye; H Mallmin et al. (2000). Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. (ekstern lenke)
• Elinor Margrethe Chelsom Vogt; Francisco Gomez Real; Eystein Sverre Husebye et al. (2022). Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. (ekstern lenke)
• Kaja Grønning; Archana Sharma; Maria Adele Mastroianni et al. (2020). Primary adrenal lymphoma as a cause of adrenal insufficiency, a report of two cases. (ekstern lenke)
• Casey J.A. Smith; Mikael Oscarson; Lars Rönnblom et al. (2011). TSGA10 – A target for autoantibodies in autoimmune polyendocrine syndrome Type 1 and systemic lupus erythematosus. (ekstern lenke)
• Anne Blomhoff; EH Kemp; DJ Gawkrodger et al. (2005). CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. (ekstern lenke)
• Hans Olav Ueland; Arve Ulvik; Kristian Løvås et al. (2023). Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. (ekstern lenke)
• Antonella Meloni; Maria Furcas; Filomena Cetani et al. (2008). Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I. (ekstern lenke)
• Eystein S.Junior Husebye; G Gebre-Medhin; T Tuomi et al. (1997). Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I correlate with the presence of autoimmune hepatitis and vitiligo. (ekstern lenke)
• Bergithe Eikeland Oftedal; Nicolas Delaleu; David William Peter Dolan et al. (2023). Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Felix Beuschlein; Tobias Else; Irina Bancos et al. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. (ekstern lenke)
• Anette Susanne Bøe Wolff; Jaanika Kärner; Jone Furulund Owe et al. (2014). Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors. (ekstern lenke)
• Øyvind Bruserud; Eystein Sverre Husebye (2015). En mann i 30-årene med diabetes og vitiligo.. (ekstern lenke)
• Mohammad Alimohammadi; Peyman Björklund; Åsa Hallgren et al. (2008). Autoimmune polyendocrine syndrome type 1 and NALP5, parathyroid autoantigen. (ekstern lenke)
• Martina Moter Erichsen; Martina M Erichsen; Kristian Løvås et al. (2009). Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry. (ekstern lenke)
• Kristian Løvås; Jon Håvard Loge; Eystein Husebye (2002). Subjective health status in Norwegian patients with Addison's disease. (ekstern lenke)
• Maria Halonen; Petra Bjørses; Anne Grethe Myhre et al. (2002). Autoimmune Regulator and Human Leucocyte Antigen Genotypes as Determinants of the Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Phenotype. (ekstern lenke)
• Geir Bredholt; Anette Margrethe Storstein; Monica Haugen et al. (2006). Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. (ekstern lenke)
• Eirik Bratland; Ng'weina Francis Magitta; Anette Susanne Bøe Wolff et al. (2013). Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. (ekstern lenke)
• Ingrid Nermoen; Ingeborg Brønstad; Kristian J Fougner et al. (2012). Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. (ekstern lenke)
• Isil Kucuka; Anette Susanne Bøe Wolff; Lars Breivik et al. (2026). Long-term follow-up of autoimmune polyendocrine syndrome type-1 in Norway. (ekstern lenke)
• Daniel Eriksson; Frida Dalin; Gabriel Nordling Eriksson et al. (2018). Cytokine autoantibody screening in the Swedish Addison Registry identifies patients with undiagnosed APS1. (ekstern lenke)
• Øyvind Bruserud; Daniela Elena Costea; Saila Laakso et al. (2018). Oral tongue malignancies in Autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Ingeborg Brønstad; Anette Susanne Bøe Wolff; Kristian Løvås et al. (2011). Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. (ekstern lenke)
• Thea Sjøgren; Eirik Bratland; Ellen Christine Røyrvik et al. (2022). Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies. (ekstern lenke)
• O Ekwall; H.H. Hedstrand; L Grimelius et al. (1998). Identification of tryptophan hydroxylase as an intestinal autoantigen. (ekstern lenke)
• Beate Skinningsrud; Einar Husebye; Eystein Sverre Husebye et al. (2009). X-Linked Congenital Adrenal Hypoplasia with Hypogonadotropic Hypogonadism Caused by an Inversion Disrupting a Conserved Noncoding Element Upstream of the NR0B1 (DAX1) Gene. (ekstern lenke)
• K Løvås; AJ Wensaas; TH Røst et al. (2009). Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. (ekstern lenke)
• Kari Lima; Tore G Abrahamsen; Anette Susanne Bøe Wolff et al. (2011). Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. (ekstern lenke)
• Iren Drange Hjellestad; Eirik Wigtil Søfteland; Eystein Sverre Husebye et al. (2018). HbA1c predicts long-term postoperative mortality in patients with unknown glycemic status at admission for vascular surgery: An exploratory study. (ekstern lenke)
• Øyvind Bruserud; Huma Siddiqui; Ileana Mihaela Cuida Marthinussen et al. (2018). Oral microbiota in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Jaanika Kärner; Anthony Meager; Maris Laan et al. (2013). Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. (ekstern lenke)
• Rosemary A. Dineen; Julie Martin-Grace; Khalid Mohamed Saeed Ahmed et al. (2023). Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy. (ekstern lenke)
• Morten Andreas Horn; Martina Moter Erichsen; Anette Susanne Bøe Wolff et al. (2013). Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease. (ekstern lenke)
• Kristian Løvås; Martina Moter Erichsen; Eystein S.Junior Husebye et al. (2005). Primær binyrebarksvikt - årsaker, diagnostikk og behandling (=Primary adrenal failure - Causes, diagnostics and therapy). (ekstern lenke)
• Marianne Catharina Astor; Kristian Løvås; Paal Methlie et al. (2024). Corticosteroid rhythms in hypoparathyroid patients. (ekstern lenke)
• Anne Grethe Myhre; Asbjørg Stray-Pedersen; E Eide et al. (2004). Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. (ekstern lenke)
• Anna L. Mitchell; Heather J. Cordell; Rachel Soemedi et al. (2009). Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility. (ekstern lenke)
• Eirik Bratland; Geir Bredholt; Gunnar Mellgren et al. (2009). The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: The major autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Eystein Husebye (2001). Acute adrenal insufficiency--symptoms and treatment. (ekstern lenke)
• E Kemp; R.A Ajjan; Eystein S.Junior Husebye et al. (1998). A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients. (ekstern lenke)
• Grethe Åstrøm Ueland; Sandra Rinne Dahl; Paal Methlie et al. (2022). Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry. (ekstern lenke)
• Anette Susanne Bøe; G. Bredholt; Per Knappskog et al. (2004). Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system. (ekstern lenke)
• Grethe Åstrøm Ueland; Eystein Sverre Husebye (2018). Metabolic complications in adrenal insufficiency. (ekstern lenke)
• Katerina Simunkova; Eystein Sverre Husebye (2016). Adrenal insufficiency therapy: How to keep the balance between good quality of life and low risk for long-term side effects?. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lars Ertesvåg Breivik; Karl Ove Hufthammer et al. (2021). The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease. (ekstern lenke)
• Kåre Kvam Hellan; Martin Madsen Lyngstad; Paal Methlie et al. (2025). Utility of Salivary Cortisol and Cortisone in the Diagnostics of Adrenal Insufficiency. (ekstern lenke)
• Anna L. Mitchell; Anette Susanne Bøe Wolff; Katie MacArthur et al. (2015). Linkage analysis in autoimmune Addison's disease: NFATC1 as a potential novel susceptibility locus. (ekstern lenke)
• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2014). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Kai Kisand; Anette Susanne Bøe Wolff; Katarina Trebusak Podkrajsek et al. (2010). Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. (ekstern lenke)
• Ng'weina Francis Magitta; Anette Susanne Bøe Wolff; Stefan Johansson et al. (2009). A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. (ekstern lenke)
• Eirik Bratland; Anette Susanne Bøe Wolff; Jan Haavik et al. (2007). Epitope mapping of human aromatic L-amino acid decarboxylase. (ekstern lenke)
• Åse Bjorvatn Sævik; Anette Susanne Bøe Wolff; Sigridur Björnsdottir et al. (2021). Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison's Disease. (ekstern lenke)
• Eirik Bratland; Alexander Hellesen; Eystein Sverre Husebye (2013). Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3. (ekstern lenke)
• Grethe Åstrøm Ueland; Tony Ernes; Tone Vonheim Madsen et al. (2022). Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes. (ekstern lenke)
• Paul Bastard; Lindsey B. Rosen; Qian Zhang et al. (2020). Autoantibodies against type I IFNs in patients with life-threatening COVID-19. (ekstern lenke)
• Alexander Hellesen; Eirik Bratland; Eystein Sverre Husebye (2018). Autoimmune Addison's disease – An update on pathogenesis. (ekstern lenke)
• Casey J.A. Smith-Anttila; Sophie Bensing; Mohammad Alimohammadi et al. (2017). Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Hanna F. Nowotny; Jillian Bryce; Salma R. Ali et al. (2023). Outcome of COVID-19 infections in patients with adrenal insufficiency and excess. (ekstern lenke)
• Kristian Løvås; Suzanne Curran; Marianne Øksnes et al. (2010). Development of a Disease-Specific Quality of Life Questionnaire in Addison's Disease. (ekstern lenke)
• Christina Bothou; Gurpreet Anand; Dingfeng Li et al. (2020). Current Management and Outcome of Pregnancies in Women with Adrenal Insufficiency: Experience from a Multicenter Survey. (ekstern lenke)
• Richard Alexander Hellesen; Kine Susann Waade Edvardsen; Lars Ertesvåg Breivik et al. (2014). The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. (ekstern lenke)
• Beate Skinningsrud; Benedicte Lie; Eystein S Husebye et al. (2010). A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis. (ekstern lenke)
• Kristian Løvås; Eystein Husebye (2002). High prevalence and increasing incidence of Addison's disease in western Norway. (ekstern lenke)
• Lars Birger Nesje; Jan Erik Varhaug; Eystein Husebye et al. (2002). Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. (ekstern lenke)
• Ingrid Nermoen; Eystein Husebye; Johan Svartberg et al. (2010). Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. (ekstern lenke)
• Åse Bjorvatn Sævik; Anna-Karin Åkerman; Paal Methlie et al. (2020). Residual Corticosteroid Production in Autoimmune Addison Disease. (ekstern lenke)
• Amund Holte Berger; Eirik Bratland; Thea Sjøgren et al. (2021). Transcriptional changes in regulatory T cells from patients with autoimmune polyendocrine syndrome type 1 suggest functional impairment of lipid metabolism and gut homing. (ekstern lenke)
• Yael Goldfarb; Tal Givony; Noam Kadouri et al. (2021). Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation. (ekstern lenke)
• AL Mitchell; HJ Cordell; R Soemedi et al. (2009). Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility. (ekstern lenke)
• Marianne Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson et al. (2018). Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism. (ekstern lenke)
• Hans Olav Ueland; Grethe Åstrøm Ueland; Kristian Løvås et al. (2022). Novel inflammatory biomarkers in thyroid eye disease. (ekstern lenke)
• Marianne Øksnes; Eystein Sverre Husebye (2023). Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults. (ekstern lenke)
• Filip Sköldberg; Guida M. Portela-Gomes; Lars Grimelius et al. (2003). Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. (ekstern lenke)
• Paul Bastard; Adrian Gervais; Maki Taniguchi et al. (2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. (ekstern lenke)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (ekstern lenke)
• Jan Dobeš; Osher Ben-Nun; Amit Binyamin et al. (2022). Extrathymic expression of Aire controls the induction of effective T<inf>H</inf>17 cell-mediated immune response to Candida albicans. (ekstern lenke)
• Eystein Sverre Husebye; Bruno Allolio; Wiebke Arlt et al. (2014). Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. (ekstern lenke)
• Jan Inge Sørheim; Eystein Sverre Husebye; Bjørn Gunnar Nedrebø et al. (2010). Phenotypic Variation in a Large Family with Autosomal Dominant Hypocalcaemia. (ekstern lenke)
• Bergithe Eikeland Oftedal; Olle Kämpe; Anthony Meager et al. (2011). Measuring autoantibodies against IL-17F and IL-22 in Autoimmune Polyendocrine Syndrome Type I by radioligand binding assay using fusion proteins. (ekstern lenke)
• Åse Bjorvatn Sævik; Grethe Åstrøm Ueland; Anna-Karin Åkerman et al. (2023). Altered biomarkers for cardiovascular disease and inflammation in autoimmune Addison's disease - a cross-sectional study. (ekstern lenke)
• Anna L. Mitchell; Katie D.R. Macarthur; Earn H. Gan et al. (2014). Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European Cohorts. (ekstern lenke)
• Haalen van Haalen; M. Kaya; I.C.M. Pelsma et al. (2022). Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN). (ekstern lenke)
• Eystein Sverre Husebye; Frederik Castinetti; Sherwin Criseno et al. (2022). Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. (ekstern lenke)
• Thomas J. Upton; Eder Zavala; Paal Methlie et al. (2023). High-resolution daily profiles of tissue adrenal steroids by portable automated collection. (ekstern lenke)
• Eystein Sverre Husebye; Jaakko Perheentupa; Riina Rautemaa et al. (2009). Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Liv Hapnes; Nick Willcox; Bergithe Eikeland Oftedal et al. (2012). Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. (ekstern lenke)
• Beata Toth; Anette Susanne Bøe Wolff; Zita Halász et al. (2010). Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. (ekstern lenke)
• D. Astuti; F. Latif; A. Dallol et al. (2001). Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. (ekstern lenke)
• Håkan Hedstrand; Olov Ekwall; Mats J. Olsson et al. (2001). The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Eystein S.Junior Husebye; Sylvi Aanderud (1998). Primær binyrebarksvikt - en diagnostisk utfordring. (ekstern lenke)
• Anette Susanne Bøe; Geir Bredholt; Per Knappskog et al. (2004). Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. (ekstern lenke)
• Beate Skinningsrud; Eystein Sverre Husebye; Kristina Gervin et al. (2008). Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Alexander Hellesen; Martina Moter Erichsen et al. (2015). Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. (ekstern lenke)
• Elizaveta M. Orlova; Leila S. Sozaeva; Maria A. Kareva et al. (2017). Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.. (ekstern lenke)
• Olov Ekwall; Håkan Hedstrand; Jan Haavik et al. (2000). Pteridine-dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Marianne Aardal Grytaas; Siri S. Strømsøy; Jarle Rørvik et al. (2017). Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population. (ekstern lenke)
• Eystein Sverre Husebye; Kristian Løvås (2009). Pathogenesis of primary adrenal insufficiency. (ekstern lenke)
• Sandra Rinne Dahl; Ingrid Nermoen; Ingeborg Brønstad et al. (2018). Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.. (ekstern lenke)
• Hanna Nowotny; Uta Neumann; Veronique Tardy-Guidollet et al. (2022). Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe. (ekstern lenke)
• Grethe Åstrøm Ueland; Paal Methlie; Anette Heie et al. (2023). Substantial changes in inflammatory and cardiovascular biomarkers in patients with autonomous cortisol secretion. (ekstern lenke)
• Paul Bastard; Adrian Gervais; Tom Le Voyer et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. (ekstern lenke)
• Dmytro Fishman; Kai Kisand; Christina Hertel et al. (2017). Autoantibody repertoire in APECED patients targets two distinct subgroups of proteins. (ekstern lenke)
• Nils Landegren; Mina Pourmousa Lindberg; Jakob Skov et al. (2016). Autoantibodies targeting a collecting duct-specific water channel in tubulointerstitial nephritis. (ekstern lenke)
• HH Hedstrand; O Ekwall; Jan Haavik et al. (2000). Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Marissa Penna-Martinez; Natalie Filmann; Dimitra Bogdanou et al. (2018). High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial. (ekstern lenke)
• Trine Elholm Bjånesøy; Bettina Kulle; Eirik Bratland et al. (2014). Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. (ekstern lenke)
• Amina Dawoodji; Ji-Li Chen; Dawn Shepherd et al. (2014). High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. (ekstern lenke)
• Nils Landegren; Donald Sharon; Anthony K. Shum et al. (2015). Transglutaminase 4 as a prostate autoantigen in male subfertility. (ekstern lenke)
• Grethe Åstrøm Ueland; Paal Methlie; Ralf Kellmann et al. (2017). Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. (ekstern lenke)
• Marianne Astor; Kristian Løvås; Aleksandra Debowska et al. (2016). Epidemiology and health-related quality of life in hypoparathyroidism in Norway. (ekstern lenke)
• Thea Sjøgren; shahinul islam; Igor Filippov et al. (2024). Single cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• G Gebre-Medhin; Eystein S.Junior Husebye; F Rorsman et al. (1997). Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• L.S. Sozaeva; E.M. Orlova; Bergithe Eikeland Oftedal et al. (2016). Antibodies against NALP5 and it's role in hypoparathyroidism in autoimmune polyglandular syndrome type 1. (ekstern lenke)
• Mads Aarhus; Ove Bruland; Geir Bredholt et al. (2008). Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. (ekstern lenke)
• Kristian Løvås; Thor Elias Thorsen; Eystein S.Junior Husebye (2006). Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. (ekstern lenke)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Stefan Johansson et al. (2008). AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. (ekstern lenke)
• Elinor Margrethe Chelsom Vogt; Katrin Hammerling; Halfdan Sorbye et al. (2021). Feminizing adrenal tumor identified by plasma steroid profiling. (ekstern lenke)
• Petter Schandl Sanaker; Eystein S.Junior Husebye; Ove Fondenes et al. (2007). Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure. (ekstern lenke)
• Amund Holte Berger; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2025). High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys. (ekstern lenke)
• Anthony Meager; Kumuthini Visvalingam; Pärt Peterson et al. (2006). Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. (ekstern lenke)
• Øyvind Bruserud; Bergithe Eikeland Oftedal; Nils Landegren et al. (2016). A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Beate Skinningsrud; Benedicte Alexandra Lie; Eystein Husebye et al. (2009). A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis. (ekstern lenke)
• Marianne Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson et al. (2018). Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism. (ekstern lenke)
• Hans Olav Ueland; Grethe Åstrøm Ueland; Kristian Løvås et al. (2022). Novel inflammatory biomarkers in thyroid eye disease. (ekstern lenke)
• Marianne Øksnes; Eystein Sverre Husebye (2023). Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults. (ekstern lenke)
• Filip Sköldberg; Guida M. Portela-Gomes; Lars Grimelius et al. (2003). Histidine decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells. (ekstern lenke)
• Paul Bastard; Adrian Gervais; Maki Taniguchi et al. (2024). Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. (ekstern lenke)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (ekstern lenke)
• Jan Dobeš; Osher Ben-Nun; Amit Binyamin et al. (2022). Extrathymic expression of Aire controls the induction of effective T<inf>H</inf>17 cell-mediated immune response to Candida albicans. (ekstern lenke)
• Eystein Sverre Husebye; Bruno Allolio; Wiebke Arlt et al. (2014). Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. (ekstern lenke)
• Eystein S.Junior Husebye; Zev M. Sthoeger; Molly Dayan et al. (2005). Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. (ekstern lenke)
• Elinor Margrethe Chelsom Vogt; Lars Ertesvåg Breivik; Ellen Christine Røyrvik et al. (2021). Primary ovarian insufficiency in women with Addison's disease. (ekstern lenke)
• Grethe Åstrøm Ueland; Paal Methlie; Marianne Øksnes et al. (2018). The short cosyntropin test revisited: new normal reference range using LC-MS/MS. (ekstern lenke)
• Anne Blomhoff; Helen Kemp; David J. Gawkrodger et al. (2005). CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. (ekstern lenke)
• Ng'weina Francis Magitta; Mikulás Pura; Anette Susanne Bøe Wolff et al. (2008). Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. (ekstern lenke)
• Beate Skinningsrud; Benedicte Alexandra Lie; Ewa Lavant et al. (2011). Multiple loci in the HLA complex are associated with Addison's Disease. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (ekstern lenke)
• Yael Gruper; Anette Susanne Bøe Wolff; Liad Glanz et al. (2023). Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease. (ekstern lenke)
• Eirik Bratland; B Skinningsrud; Dag Erik Undlien et al. (2009). T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency. (ekstern lenke)
• Marianne Øksnes; Sigridur Björnsdottir; Magnus Isaksson et al. (2014). Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. (ekstern lenke)
• Anette Susanne Bøe Wolff; Kjell-Morten Myhr; Christian A. Vedeler et al. (2007). Fc gamma receptor polymorphisms are not associated with autoimmune Addison's disease. (ekstern lenke)
• Ingrid Nermoen; Jarle Rørvik; Stein Harald Holmedal et al. (2011). High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency. (ekstern lenke)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Eirik Bratland et al. (2008). Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (ekstern lenke)
• O Ekwall; H.H. Hedstrand; L Grimelius et al. (1998). Identification of tryptophan hydroxylase as an intestinal autoantigen. (ekstern lenke)
• Nora Møller Didriksen; Åse Bjorvatn Sævik; Linn Solveig Sortland et al. (2021). Sex-Specific Limitations in Physical Health in Primary Adrenal Insufficiency. (ekstern lenke)
• F. Skoldberg; F. Rorsman; J. Perheentupa et al. (2004). Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease. (ekstern lenke)
• Svetlana Vakkilainen; Riikka Makitie; Paula Klemetti et al. (2018). A wide spectrum of autoimmune manifestations and other symptoms suggesting immune dysregulation in patients with cartilage-hair hypoplasia. (ekstern lenke)
• Anne Blomhoff; Benedicte a. Lie; A.G. Myhre et al. (2004). Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. (ekstern lenke)
• Sigrid Aslaksen; Paal Methlie; Magnus Dehli Vigeland et al. (2019). Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. (ekstern lenke)
• Kine Susann Waade Edvardsen; Trine Elholm Bjånesøy; Alexander Hellesen et al. (2015). Peripheral blood cells from patients with autoimmune Addison's disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines. (ekstern lenke)
• Alberto Falorni; Vittorio Bini; Corrado Betterle et al. (2015). Determination of 21-hydroxylase autoantibodies: Inter-laboratory concordance in the Euradrenal International Serum Exchange Program. (ekstern lenke)
• Martina Moter Erichsen; Martina M Erichsen; K Lovas et al. (2009). Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. (ekstern lenke)
• Bergithe Eikeland Oftedal; Kristian Assing; Safa Baris et al. (2023). Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes. (ekstern lenke)
• Paul Bastard; Elizaveta Orlova; Leila S. Sozaeva et al. (2021). Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. (ekstern lenke)
• Eystein S.Junior Husebye; Anette Susanne Bøe; F Rorsman et al. (2000). Inhibition of aromatic 1-amino acid decarboxylase by human autoantibodies. (ekstern lenke)
• A Søderbergh; F Rorsman; M Halonen et al. (2000). Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (ekstern lenke)
• Marianne Øksnes; Sophie Bensing; Anna-Lena Hulting et al. (2012). Quality of life in European patients with Addison's Disease: Validity of the disease-specific questionnaire AddiQoL. (ekstern lenke)
• Kristian Løvås; Eystein S.Junior Husebye (2007). Continuous subcutaneous hydrocortisone infusion in Addison's disease. (ekstern lenke)
• Isil Kucuka; Dorsa Iraji; Sarah Braun et al. (2025). Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. (ekstern lenke)
• Kristian Løvås; Thor S Trovik; Kristian J Fougner et al. (2003). Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Healt Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial. (ekstern lenke)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Kai Kisand et al. (2010). Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Guri Fossdal; Peder Rustøen Braadland; Johannes Espolin Roksund Hov et al. (2025). Mitochondrial dysfunction and lipid alterations in primary sclerosing cholangitis. (ekstern lenke)
• Alessandro Prete; Anuradhaa Subramanian; Irina Bancos et al. (2022). Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors A Cross-Sectional Multicenter Study. (ekstern lenke)
• Kristian Løvås; K Lovas; Therese Halvorsen Røst et al. (2009). Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. (ekstern lenke)
• Kristian Løvås; Clara G Gjesdal; Monica Christensen et al. (2009). Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. (ekstern lenke)
• Antonella Meloni; Nick Willcox; Anthony Meager et al. (2012). Autoimmune polyendocrine syndrome Type 1: an Eetensive longitudinal study in Sardinian patients. (ekstern lenke)
• Muhammad Rahman; André Sulen; Lars Ertesvåg Breivik et al. (2025). Anti-perilipin-1 autoantibodies in autoimmune Addison’s disease and related endocrine disorders. (ekstern lenke)
• Alexander Hellesen; Sigrid Aslaksen; Lars Ertesvåg Breivik et al. (2021). 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules. (ekstern lenke)
• Marta Fichna; Magdalena Zurawek; Eirik Bratland et al. (2015). Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis. (ekstern lenke)
• Grethe Åstrøm Ueland; Ralf Kellmann; Melissa Davidsen Jørstad et al. (2021). Bedtime Salivary Cortisol as a Screening Test for Cushing Syndrome in Children. (ekstern lenke)
• Sigridur Björnsdottir; Marianne Øksnes; Magnus Isaksson et al. (2015). Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. (ekstern lenke)
• Anthony K. Shum; Mohammad Alimohammadi; Catherie L. Tan et al. (2013). BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. (ekstern lenke)
• Anne Grethe Myhre; Dag Erik Undlien; Kristian Løvås et al. (2002). Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. (ekstern lenke)
• Bjørn G Nedrebø; Pål Ivar Holm; Sverre Uhlving et al. (2002). Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease. (ekstern lenke)
• Katerina Simunkova; Nevena Jovanovic; Espen Rostrup et al. (2016). Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. (ekstern lenke)
• Kristian Løvås; Suzanne Curran; Marianne Øksnes et al. (2009). Development of a Disease-Specific Quality of Life Questionnaire in Addison’s Disease. (ekstern lenke)

Konferanseforedrag

• Eystein Husebye (2002). Autoimmune polyendocrine syndromes. (ekstern lenke)
• T Rygh; Eystein S.Junior Husebye (1997). Ductal autoantigens in Sjøgren's syndrome. (ekstern lenke)
• Eystein Husebye (2002). Pituitary tumours in multiple endocrine neoplasia type 1. (ekstern lenke)
• Kristian Løvås; Eystein Husebye (2002). Prevalens og insidens av Addison's sykdom i Vest-Norge Livskvalitet hos pasienter med Addison's sykdom. (ekstern lenke)
• Eystein Husebye (2003). Meet the expert session on "Hypoadrenalism: substitution by corticoids and androgens". (ekstern lenke)
• Eystein Husebye (2003). Autoimmune polyendocrine syndromes. (ekstern lenke)
• E Bratland; G Bredholt; Per Knappskog et al. (2005). Cellular immunity to 21-hydroxylase in patients with autoimmune Addison's disease. (ekstern lenke)
• Kristian Løvås; Eystein Husebye (2002). Dehydroepiandrosterone replacement in adrenal failure. (ekstern lenke)
• Eystein Husebye (2003). Autoimmune Addisons disease and polyendocrine syndromes. (ekstern lenke)
• D Hammenfors; Kristian Løvås; G Bredholt et al. (2005). Variable expression of FKBP51 in Addison's Disease - a parameter of glucocorticoid sensitivity ?. (ekstern lenke)
• Eystein Husebye (2001). Klinisk handläggning av APS I patienter. (ekstern lenke)
• M Pura; M Straka; D Felcanová et al. (2005). Ganglioneuroma in patient with adrenal insufficiency - rare coincidence of adrenal cortex and medulla disorders. (ekstern lenke)
• M Pura; A Pelet; M Grófik et al. (2005). Severe neurological impairment in patient with allgrove syndrome caused by frame shift mutation G363X (1066-1067delCT) and novel missense mutation W272S (TGG->TCG). (ekstern lenke)

Konferanseposter

• Anette Susanne Bøe; Ola Winqvist; Per Morten Knappskog et al. (2002). Autoantibodies Against SCC in Addison`s Disease, APS I and in APS II Are Mainly IgG1. (ekstern lenke)
• Anne Grethe Myhre; Hildegunn Årsetøy; Dag Erik Undlien et al. (2002). High frequency of celiac disease among patients with autoimmune adrenocortical failure. (ekstern lenke)
• Anette Susanne Bøe; Geir Bredholt; Christian A Vedeler et al. (2003). Identification of a novel paraneoplastic autoantigen with phosphatase- and hydrolase-like domains in the central nervous system. (ekstern lenke)
• Anne Grethe Myhre; Nils Hovdenak; Eystein Husebye et al. (2002). High Frequency of Celiac Disease among Patients with Autoimmune Adrenocortical Failure. (ekstern lenke)
• Morten Christoph Eike; Beate Skinningsrud; Benedicte Alexandra Lie et al. (2011). No association with RFX, CCR5 or CD226 polymorphisms in Norwegian Addison’s disease patients. (ekstern lenke)
• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Eirik Bratland et al. (2013). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with APS-1. (ekstern lenke)
• Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen; Malin V Jonsson et al. (2011). Oral Manifestations of Autoimmune PolyendocrineSyndrome Type I. (ekstern lenke)
• Morten Christoph Eike; Beate Skinningsrud; Benedicte Alexandra Lie et al. (2011). No association with RFX, CCR5 or CD226 polymorphisms in Norwegian Addison’s disease patients. (ekstern lenke)
• Anne Grethe Myhre; Asbjørg Stray-Pedersen; Eigill Eide et al. (2002). Primary hypothyroidism and chronic mucocutaneous candidiasis in three siblings. (ekstern lenke)
• Kristian Løvås; Thor Thorsen; Eystein Husebye (2003). Salivary cortisol measurement in the assessment of the glucocorticoid replacement therapy in Addison's disease. (ekstern lenke)

Konferanseabstrakt

• Paal Methlie; Kristian Løvås; Ernst Asbjørn Lien et al. (2010). Grapefruit and Liquorice Increase Bioavailable Cortisol in Addison's Disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Martina Moter Erichsen; Alexander Hellesen et al. (2013). Dominant Inheritance in Autoimmune Endocrine Syndrome Type 1. (ekstern lenke)
• Åsa Hallgren; Mina Pourmousa; Jakob Skov et al. (2010). Immunoreactivity against kidney collecting ducts in patients with autoimmune polyendocrine syndrome type 1 and systemic hypertension. (ekstern lenke)
• M Cheng; M Barnes; A Mehta et al. (2009). Loss of AIRE Expression in Thymoma Tissue Associated with Multiple Endocrine Autoimmunity: A Novel Case of APS1. (ekstern lenke)
• B.E.V. Oftedal; A Meager; Eystein Sverre Husebye et al. (2012). Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyedocrine sydnrome type I. (ekstern lenke)
• Ingeborg Brønstad; Beate Skinningsrud; Anette Susanne Bøe Wolff et al. (2013). Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. (ekstern lenke)
• Eirik Bratland; Richard Alexander Hellesen; Eystein Sverre Husebye (2012). Mice deficient for the autoimmune regulator, Aire, display altered T cell responses against 21-hydroxylase, the major autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2010). The Possible Roles of Interferon-Gamma, CXC Chemokine Ligand 10 (CXCL10) and the CXCR3 Circuit in the Pathogenesis of Autoimmune Addison's Disease. (ekstern lenke)
• Anette Susanne Bøe Wolff; A. Ostre; Bergithe Eikeland Oftedal et al. (2012). Deviant expression of defensins in sera and saliva of patients with autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2008). 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Olle Kämpe et al. (2010). Nucleoporin 62, a Novel Autoantigen in Patients with Autoimmune Polyendocrine Syndrome Type I (APS I). (ekstern lenke)
• A Hellesen; Eirik Bratland; Eystein Sverre Husebye (2012). Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease?. (ekstern lenke)
• Richard Alexander Hellesen; Eirik Bratland; Eystein Sverre Husebye (2011). Endogenous Production of CXC Chemokine Ligand 10 (CXCL10) by Adrenocortical Cells and its Implications for Autoimmune Addison's Disease. (ekstern lenke)
• Eirik Bratland; Anette Susanne Bøe Wolff; Jan Haavik et al. (2007). Epitope mapping of human aromatic L-amino acid decarboxylase. (ekstern lenke)
• Martina M. Erichsen; Eystein Sverre Husebye; Alv A Dahl et al. (2010). Sexuality, Fertility and Androgens in Women with Addison's Disease. (ekstern lenke)
• Marissa Penna-Martinez; Julia M. Schwartz; Faroquhi Shoghi et al. (2013). Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease. (ekstern lenke)
• Ileana Mihaela Cuida Marthinussen; Martina Moter Erichsen; Malin V Jonsson et al. (2011). Oral manifestations of autoimmune polyendocrine syndrome type I. (ekstern lenke)

Fagartikkel

• Ingrid Nermoen; Eystein Sverre Husebye; Anne Grethe Myhre et al. (2017). Klassisk medfødt binyrebarkhyperplasi. (ekstern lenke)
• Eystein Sverre Husebye; Martina Ericksen; A-G Myhre et al. (2012). Nytt steroidkort ved binyrebarksvikt. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Hanna Nowotny; S. Faisal Ahmed; Sophie Bensing et al. (2021). Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. (ekstern lenke)
• Eystein Sverre Husebye; Mark S. Anderson (2010). Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. (ekstern lenke)
• Anna-Karin Åkerman; Åse Bjorvatn Sævik; Per Medbøe Thorsby et al. (2023). Plasma-Metanephrines in Patients with Autoimmune Addison’s Disease with and without Residual Adrenocortical Function. (ekstern lenke)
• Sandra Dis Steintorsdottir; Marianne Øksnes; Anders Palmstrøm Jørgensen et al. (2025). Extended-release Hydrocortisone Formulations - Is There a Clinically Meaningful Benefit?. (ekstern lenke)
• Eystein Sverre Husebye; Simon H. Pearce; Nils P. Krone et al. (2021). Adrenal insufficiency. (ekstern lenke)
• Anette Susanne Bøe Wolff; Sarah Braun; Eystein Sverre Husebye et al. (2021). B cells and autoantibodies in aire deficiency. (ekstern lenke)
• Eystein Sverre Husebye; Guillaume Assié; Nils Krone et al. (2025). EndoCompass project: research roadmap for adrenal and cardiovascular endocrinology. (ekstern lenke)
• Eystein Sverre Husebye; Kristian Løvås (2009). Immunology of Addison's Disease and premature ovarian failure. (ekstern lenke)
• Øyvind Bruserud; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2016). AIRE-mutations and autoimmune disease. (ekstern lenke)
• Stefanie Hahner; Richard Ross; Wiebke Arlt et al. (2021). Adrenal insufficiency. (ekstern lenke)
• Ellen Christine Røyrvik; Eystein Sverre Husebye (2022). The genetics of autoimmune Addison disease: past, present and future. (ekstern lenke)
• Eystein Sverre Husebye; Mark S. Anderson; Olle Kämpe (2018). Autoimmune polyendocrine syndromes. (ekstern lenke)
• Sophie Bensing; Anna-Lena Hulting; Eystein Sverre Husebye et al. (2016). Management of endocrine disease - Epidemiology, quality of life and complications of primary adrenal insufficiency: A review. (ekstern lenke)
• Sergueï O. Fetissov; Sophie Bensing; Jan Mulder et al. (2009). Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems. (ekstern lenke)
• Qian Zhang; Paul Bastard; Adem Karbuz et al. (2022). Human genetic and immunological determinants of critical COVID-19 pneumonia. (ekstern lenke)
• Kristian Løvås; Eystein Sverre Husebye (2008). Replacement therapy for Addison's disease: recent developments. (ekstern lenke)
• Jakub Abramson; Eystein Sverre Husebye (2016). Autoimmune regulator and self-tolerance - molecular and clinical aspects. (ekstern lenke)

Masteroppgave

• Eirik Bratland; Eystein S.Junior Husebye; Anne Marie Szilvay (2005). Cellular immunity in autoimmune Addison's disease. (ekstern lenke)
• Yeweyenhareg Feleke; Eystein S.Junior Husebye (2005). Studies of Addison's disease in Ethiopia. (ekstern lenke)

Doktorgradsavhandling

• Grethe Åstrøm Ueland; Eystein Sverre Husebye; Paal Methlie et al. (2019). Improved diagnostic workup of hyper- and hypocortisolism. (ekstern lenke)
• Anette Susanne Bøe; Eystein S.Junior Husebye (2005). Immunological perspectives of autoimmune polyendocrine syndromes and cancer. (ekstern lenke)
• Eystein S.Junior Husebye (1990). Stimulus-secretion coupling in chromaffin cells of the bovine adrenal medulla : with special reference to the role of phospholipid metabolism. (ekstern lenke)
• Øyvind Bruserud; Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal et al. (2019). Exploring and redefining Autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Anne Grethe Myhre; Eystein S.Junior Husebye (2004). Studies of autoimmune adrenocortical failure and polyendocrine syndromes. (ekstern lenke)
• Iren Drange Hjellestad; Torbjörn Jonung; Eystein Sverre Husebye et al. (2019). Biomarkers for Diabetes Mellitus in advanced Peripheral Arterial Disease. Diagnostic performance and outcome prediction of HbA1c, fasting plasma glucose and the oral glucose tolerance test. (ekstern lenke)
• Ingeborg Brønstad; Eystein Sverre Husebye (2015). Genetics of autoimmune Addison´s disease and congenital adrenal hyperplasia. (ekstern lenke)

Forskningsrapport

• Eystein S.Junior Husebye (2000). Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. (ekstern lenke)
• Eystein Husebye (2000). Feokromocytom i Neuroindokrine tumorer, en veiledning til diagnostikk og behandling. (ekstern lenke)

Vitenskapelig bokkapittel

• Eystein Husebye (2003). Cushings syndrom. (ekstern lenke)
• Anette Susanne Bøe Wolff; Bergithe Eikeland Oftedal; Eystein Sverre Husebye (2019). The Natural History of APS1. (ekstern lenke)

Lærebok

• Eystein Sverre Husebye; Kristian Løvås (2017). Endokrinologi, en medisinsk lærebok. (ekstern lenke)

Leserbrev

• Cecilie Smith Ødegaard; May Brit Samersaw-Lund; Radek Frič et al. (2024). Etisk ryggrad i møte med politisk konflikt. (ekstern lenke)
• Marianne Grytaas; Lars Ertesvåg Breivik; Jørgensen Anders Palmstrøm et al. (2020). Medisinsk koding til besvær. (ekstern lenke)
• Daniel Eriksson; Rosa Bacchetta; Hörður Ingi Gunnarsson et al. (2019). The autoimmune targets in IPEX are dominated by gut epithelial proteins. (ekstern lenke)
• Eystein Sverre Husebye (2008). Endokrinologisk akuttmedisin. (ekstern lenke)
• Marcus Quinkler; Per Dahlqvist; Eystein Sverre Husebye et al. (2015). A European Emergency Card for adrenal insufficiency can save lives. (ekstern lenke)
• Kristian Løvås; Eystein S.Junior Husebye (2005). Addison's disease. (ekstern lenke)
• Petter Brodin; Giorgio Casari; Liam Townsend et al. (2022). Studying severe long COVID to understand post-infectious disorders beyond COVID-19. (ekstern lenke)
• M Cheng; U Fan; N Grewal et al. (2010). Acquired Autoimmune Polyglandular Syndrome, Thymoma, and an AIRE Defect. (ekstern lenke)
• Tor-Arne Hegvik; Eystein Sverre Husebye; Jan Haavik (2014). Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). (ekstern lenke)
• Kristian Løvås; Eystein S.Junior Husebye (2004). Replacement therapy in Addison&apos;s disease. (ekstern lenke)
• Eystein Sverre Husebye (2012). E. S. Husebye svarer. (ekstern lenke)

Forelesning

• Eystein S.Junior Husebye (1997). Adrenal insufficiency, diagnostic and molecular biology. (ekstern lenke)
• Eystein S.Junior Husebye (1997). Autoantibodies against L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease. (ekstern lenke)

Lederartikkel

• Eystein Husebye (2002). Hypotyreose. (ekstern lenke)
• Eystein Sverre Husebye (2009). Functional autoantibodies cause hypoparathyroidism. (ekstern lenke)
• Ian Louis Ross; Eystein Sverre Husebye; Michelle Henry (2023). Editorial: Glucocorticoids and cognition: recent advances in understanding their interaction, with a particular focus on clinical applicability for the treating endocrinologist. (ekstern lenke)
• Eystein Sverre Husebye (2009). Editorial: Functional Autoantibodies Cause Hypoparathyroidism. (ekstern lenke)

Kapittel i fagbok

• Eystein Sverre Husebye (2017). Binyresykdommer. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

Ten papers of special significance

1. Ueland GÅ, Methlie P, Jøssang DE, Sagen JV, Viste K, Thordarson HB, Heie A, Grytaas M, Løvås K, Biermann M, Husebye ES. Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion. J Clin Endocrinol Metab. 2018 Dec 1;103(12):4553-4560. First major study showing the importance of adrenal venous sampling in the evaluation of adrenal Cushing’s syndrome.

2. Ueland GÅ, Methlie P, Øksnes M, Thordarson HB, Sagen J, Kellmann R, Mellgren G, Ræder M, Dahlqvist P, Dahl SR, Thorsby PM, Løvås K, Husebye ES. The short cosyntropintest revisited - new normal reference range using LCMSMS. J Clin Endocrinol Metab. 2018 Feb 14. doi: 10.1210/jc.2017-02602. [Epub ahead of print]. First major re-evaluation of the short synacthen test using LCMSMS.

3. Husebye ES, Anderson MS, Kämpe O. Autoimmune polyendocrine syndromes. New Engl.J Med, 378, 1132-41, 2018 (IF 72.4). Invited review that summarizes the current status on polyendocrine syndromes.

4. Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, Wolff ASB, Breivik L, Zakharova EY, Ivanova ON, Kämpe O, Dedov II, Knappskog PM, Peterkova VA, and Husebye ES. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type-1. J Clin Endocrinol Metabol 102, 3546-56, 2017 (IF 5.5). Clinical and immunological characterization of the hitherto largest cohort of patients with autoimmune polyendocrine syndrome type 1 in the world.

5. Landegren N, Sharon D, Shum AK, Khan IS, Fasano K, Hallgren Å, Kampf C, Freyhult E, Ardesjö-Lundgren B, Alimohammadi M, Rathsman S, Ludvigsson JF, Hedelin H, Lundh D, Motrich R, Rivero V, Fong L, Giwercman A, Gustafsson J, Perheentupa J, Husebye ES, Anderson MS, Snyder M, Kämpe O. Prostatic transglutaminase 4 as a male-specific autoantigen. Science Trans Med 2015 7(292):292ra101. (IF 16.8). Identification of transglutaminase 4 as the first geneder-specific autoantigen assosiated with autoimmune prostatitis. Transglutaminase 4 is an autoantigen in both humans and in autoimmune regulator knockout mice. Furthermore it was demonstrated that transglutaminase 4 belows to the family of aire-regulated genes.

6. Chuprin C, Avin A, Goldfarb Y, Herzig Y, Levi B, Jacob A, Sela A, Katz S1, Grossman M, Guyon C, Rathaus M, Cohen H, Sagi I, Giraud M, McBurney M, Husebye ES, Abramson J. Sirt1 is essential for Aire-mediated induction of central immunological tolerance. Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance. Nature Immunology 16,737-45, 2015, (IF 21.5). Demonstration of Sirtuin-1 as a key regulator of AIRE by deacetylation using mouse models. Sirt1-mutations have been described in monogenic autoimmune diabetes mellitus type 1

7. Oftedal BE, Hellesen A, Erichsen MM, Bratland B, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WAC, Sozaeva LG, Zayats T, Haugarvoll K, Orlova EM, Haavik J Johansson S, Knappskog PM, Løvås L, Wolff ASB, Abramson J, Husebye ES. Dominant Autoimmune Regulator mutations associated with common organ-specific autoimmune diseases. Immunity 42,1185-96, 2015. (IF 22.8). Identification of a new mechanism for familial autoimmunity by identification of several dominant negative mutations in the autoimmune regulator gene. The study includes clinical and immunological characterization of patients as well as functional studies of the mutants demonstrating the dominant negative effect. The paper was accompanied by an editorial and front page cover illustration (June issue).

8. Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, Kämpe O, Cerundolo V. High Frequency of Cytolytic 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Patients. J Immunol 193, 2118-26, 2014 (IF 4.8). Demonstration of both CD8 and CD4 T cell reativity against 21-hydroxylase and identification of distinct epitopes, building on previous observation by us Bratland et al JCEM, 2009 and Husebye et al, Endocrinology, 2005.

9. Mitchell AL, Macarthur KD, Gan EH, Baggott LE, Wolff AS, Skinningsrud B, Platt H, Short A, Lobell A, Kämpe O, Bensing S, Betterle C, Kasperlik-Zaluska A, Zurawek M, Fichna M, Kockum I, Nordling Eriksson G, Ekwall O, Wahlberg J, Dahlqvist P, Hulting AL, Penna-Martinez M, Meyer G, Kahles H, Badenhoop K, Hahner S, Quinkler M, Falorni A, Phipps-Green A, Merriman TR, Ollier W, Cordell HJ, Undlien D, Czarnocka B, Husebye ES, Pearce SH. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts. Plos One, 9(3):e88991. doi: 10.1371/journal.pone.0088991. eCollection 2014. (IF 3.5). Results of a FP7-Euradrenal (coordinator Husebye) to find novel disease associations in autoimmune Addison’s disease involving Addison cohorts from 6 European countries totalling over 2000 patients with autoimmune Addison’s disease. Several novel associations were found including GATA3 and STAT4

10. Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K. Continuous Subcutaneous Hydrocortisone Infusion versus Oral Hydrocortisone Replacement for Treatment of Addison's Disease: A Randomized Clinical Trial. J Clin Endocrinol Metabol 99,1665-74, 2014. (IF 5.5). Clinical study of circadian cortisol treatment first introduced by us. Using subcutaneous cintinous infusion of cortisol by an insulin pump we were able to restore circadian levels of cortisol. The preatment was safe and patients reported improved quality of life.

Leder K.G. Jebsen-senter for autoimmune sykdommer

Koordinator av H2020 Ultradian